Patents by Inventor Annelise Genoux

Annelise Genoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject
    Patent number: 9945871
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: April 17, 2018
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux
  • METHOD FOR ASSESSING A SUBJECT'S RISK OF HAVING A CARDIOVASCULAR DISEASE
    Publication number: 20150226749
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 13, 2015
    Applicants: Institut National de la Santé et de la Recherche Médicale (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent MARTINEZ, Bertrand PERRET, Annelise GENOUX
  • Method for assessing a subject's risk of having a cardiovascular disease
    Patent number: 9052326
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: June 9, 2015
    Assignees: Institut National de la Santé et de la Recherche Médicale (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux
  • METHOD FOR ASSESSING A SUBJECT'S RISK OF HAVING A CARDIOVASCULAR DISEASE
    Publication number: 20130310315
    Abstract: The present invention relates to a method for assessing a subject's risk of having a cardiovascular disease comprising the step of measuring the level of IF1 in a body fluid sample obtained from said subject wherein the level of EF1 is negatively correlated with the risk of said subject of having cardiovascular disease.
    Type: Application
    Filed: January 25, 2012
    Publication date: November 21, 2013
    Applicants: Institut National de la Sante et de la Recherche Medicale(Inserm), CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Laurent Martinez, Bertrand Perret, Annelise Genoux